GenSight Biologics S.A. announced the appointment of Scott Jeffers as new Chief Technical Officer overseeing manufacturing and supply chain operations.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.39 EUR | -1.02% | -4.41% | -15.22% |
May. 07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.22% | 43.43M | |
+9.49% | 114B | |
+13.05% | 107B | |
-6.69% | 22.22B | |
-1.43% | 21.28B | |
-4.55% | 18.8B | |
-6.02% | 17.51B | |
-39.36% | 17.17B | |
+6.22% | 14.14B | |
+34.71% | 12.2B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- Gensight Biologics S.A. Names Scott Jeffers as Chief Technical Officer